Join us as we discuss the Seraph-100, a blood filtration medical device. This device was used among cancer patients who were hopeful for a cure. The company behind the device was charged with concealing adverse events, including patient deaths. Dee and Ris discuss the medical and psychiatric perspectives behind this case, based upon their experiences as nurses.

Sources

https://www.justice.gov/opa/pr/former-exthera-medical-corporation-executive-admits-concealing-patient-deaths-fda

https://www.reuters.com/legal/government/blood-filter-start-up-ex-executive-face-us-charges-concealing-deaths-2026-03-06

https://www.justice.gov/usao-ma/pr/chief-regulatory-office-exthera-medical-charged-concealing-adverse-events-including